Literature DB >> 16282279

Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.

Rhonda F Souza1, Stuart J Spechler.   

Abstract

For decades, the incidence rates for squamous cell carcinoma of the esophagus and adenocarcinoma of the distal stomach have been declining while the rates for adenocarcinomas of the esophagus and gastric cardia have increased profoundly. Recent studies have shown that the gastroesophageal junction (GEJ) is regularly exposed to concentrated gastric acid and to a variety of nitrosating species, noxious agents that may contribute to carcinogenesis in this region. For adenocarcinomas that straddle the GEJ, it can be difficult to determine whether the tumor originated in the esophagus or in the gastric cardia. This classification problem hampers studies on the epidemiology and pathogenesis of GEJ tumors. Current concepts in the prevention of cancers of the distal esophagus and proximal stomach have emerged from advances in our understanding of the specific molecular events that occur during the evolution of these tumors. This report reviews those events and focuses on current concepts in the prevention of adenocarcinomas at the GEJ. The similarities and differences in risk factors, molecular pathogenesis, and in preventive strategies for adenocarcinomas of the esophagus and gastric cardia are highlighted.

Entities:  

Mesh:

Year:  2005        PMID: 16282279     DOI: 10.3322/canjclin.55.6.334

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  32 in total

1.  Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro.

Authors:  Chun-xiao Xu; Yun-fei Yan; Ya-pei Yang; Bin Liu; Jia-xuan Xin; Shi-min Chen; Wei Wang; Chun-ying Jiang; Zhao-xin Lu; Xian-xi Liu
Journal:  Mol Biol Rep       Date:  2010-06-09       Impact factor: 2.316

Review 2.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 3.  Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Authors:  Bita V Naini; Rhonda F Souza; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

4.  Exposure to both radiation and chemotherapy increases the risk of Barrett's and multilayered epithelium.

Authors:  Helen M Shields; Abram Recht; Helen H Wang
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

Review 5.  Narrow band imaging in gastroesophageal reflux disease and Barrett's esophagus.

Authors:  Mitchell M Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

6.  Identification of a 5-gene signature for clinical and prognostic prediction in gastric cancer patients upon microarray data.

Authors:  Zhigang Wang; Zhi Yan; Bicheng Zhang; Zhiguo Rao; Yafei Zhang; Jian Liu; Lifang Yu; Yong Zhao; Bo Yang; Tingting Wu; Jianfei Gao
Journal:  Med Oncol       Date:  2013-08-03       Impact factor: 3.064

7.  Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway.

Authors:  Qiuyang Zhang; Chunhua Yu; Sui Peng; Hao Xu; Ellen Wright; Xi Zhang; Xiaofang Huo; Edaire Cheng; Thai H Pham; Kiyotaka Asanuma; Kimmo J Hatanpaa; Davood Rezai; David H Wang; Venetia Sarode; Shelby Melton; Robert M Genta; Stuart J Spechler; Rhonda F Souza
Journal:  Gastroenterology       Date:  2013-10-09       Impact factor: 22.682

8.  Differences in gastric cancer survival between the U.S. and China.

Authors:  Vivian E Strong; Ai-Wen Wu; Luke V Selby; Mithat Gonen; Meier Hsu; Kyo Young Song; Cho Hyun Park; Daniel G Coit; Jia-Fu Ji; Murray F Brennan
Journal:  J Surg Oncol       Date:  2015-07-14       Impact factor: 3.454

9.  Endoscopic optical coherence tomography: technologies and clinical applications [Invited].

Authors:  Michalina J Gora; Melissa J Suter; Guillermo J Tearney; Xingde Li
Journal:  Biomed Opt Express       Date:  2017-04-07       Impact factor: 3.732

Review 10.  [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].

Authors:  J C Becker; W Domschke; T Pohle
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.